[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI945665A0 - Retrovirusvektori, joka kykenee transdusoimaan aldehydidehydrogenaasi-1-geenin ja mainitun vektorin käyttö - Google Patents

Retrovirusvektori, joka kykenee transdusoimaan aldehydidehydrogenaasi-1-geenin ja mainitun vektorin käyttö

Info

Publication number
FI945665A0
FI945665A0 FI945665A FI945665A FI945665A0 FI 945665 A0 FI945665 A0 FI 945665A0 FI 945665 A FI945665 A FI 945665A FI 945665 A FI945665 A FI 945665A FI 945665 A0 FI945665 A0 FI 945665A0
Authority
FI
Finland
Prior art keywords
vector
transducing
gene
aldehyde dehydrogenase
retroviral vector
Prior art date
Application number
FI945665A
Other languages
English (en)
Swedish (sv)
Other versions
FI945665A (fi
Inventor
Riccardo Dalla-Favera
Alessandro Massimo Gianni
Original Assignee
Univ Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia filed Critical Univ Columbia
Publication of FI945665A publication Critical patent/FI945665A/fi
Publication of FI945665A0 publication Critical patent/FI945665A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/867—Retroviral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/01—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
    • C12Y102/01003—Aldehyde dehydrogenase (NAD+) (1.2.1.3)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI945665A 1993-04-01 1994-12-01 Retrovirusvektori, joka kykenee transdusoimaan aldehydidehydrogenaasi-1-geenin ja mainitun vektorin käyttö FI945665A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4172293A 1993-04-01 1993-04-01
PCT/US1994/003624 WO1994023015A1 (en) 1993-04-01 1994-04-01 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector

Publications (2)

Publication Number Publication Date
FI945665A FI945665A (fi) 1994-12-01
FI945665A0 true FI945665A0 (fi) 1994-12-01

Family

ID=21917990

Family Applications (1)

Application Number Title Priority Date Filing Date
FI945665A FI945665A0 (fi) 1993-04-01 1994-12-01 Retrovirusvektori, joka kykenee transdusoimaan aldehydidehydrogenaasi-1-geenin ja mainitun vektorin käyttö

Country Status (14)

Country Link
US (2) US5888820A (fi)
EP (1) EP0648261A4 (fi)
JP (1) JPH08501221A (fi)
KR (1) KR950701969A (fi)
CN (1) CN1109260A (fi)
AU (1) AU6623994A (fi)
CA (1) CA2135912A1 (fi)
FI (1) FI945665A0 (fi)
HU (1) HUT75717A (fi)
IL (1) IL109168A0 (fi)
NZ (1) NZ265472A (fi)
PL (1) PL306549A1 (fi)
RU (1) RU94046095A (fi)
WO (1) WO1994023015A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109168A0 (en) 1993-04-01 1994-06-24 Univ Columbia A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and making cells resistant to the chemotherapeutic agent cyclophosphamide and its derivatives and analogs
JPH08508888A (ja) * 1993-04-08 1996-09-24 コーネル・リサーチ・ファウンデーション，インコーポレイテッド グルタミルシステイン・シンセターゼ軽サブユニット
CN1078613C (zh) * 1997-12-25 2002-01-30 中国科学院遗传研究所 山菠菜甜菜碱醛脱氢酶基因以及提高植物耐盐性的方法
US6395549B1 (en) 1998-10-22 2002-05-28 Medical College Of Georgia Research Institute, Inc. Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors
MY142328A (en) 2002-03-26 2010-11-15 Ajinomoto Kk CANDIDA UTILIS CONTAINING y-GLUTAMYLCYSTEINE
WO2007065167A1 (en) * 2005-12-02 2007-06-07 The Johns Hopkins University Use of high-dose oxazaphosphorine drugs for treating immune disorders
WO2008034071A2 (en) * 2006-09-15 2008-03-20 The Johns Hopkins University Method of identifying patients suitable for high-dose cyclophosphamide treatment
WO2008034076A2 (en) 2006-09-15 2008-03-20 The Johns Hopkins University Cyclophosphamide in combination with immune therapeutics
WO2008034074A2 (en) 2006-09-15 2008-03-20 The Johns Hopkins University Cyclosphosphamide in combination with anti-idiotypic vaccines
WO2009067690A2 (en) * 2007-11-21 2009-05-28 Accentia Biopharmaceuticals, Inc. Methods for safe and effective treatment using oxazaphosphorine drugs
US9026372B2 (en) * 2007-11-21 2015-05-05 Accentia Biopharmaceuticals, Inc. Methods for providing a system of care for a high-dose oxazaphosphorine drug regimen
US20120021409A1 (en) * 2010-02-08 2012-01-26 Regeneron Pharmaceuticals, Inc. Common Light Chain Mouse
RS55042B1 (sr) * 2010-06-22 2016-12-30 Regeneron Pharma Miševi koji ispoljavaju laki lanac hibridnog imunoglobulina sa promenljivim regionom čoveka
CA2807282A1 (en) * 2010-08-02 2012-02-09 Regeneron Pharamaceuticals, Inc. Mice that make binding proteins comprising vl domains
EP3710013A4 (en) * 2017-11-15 2021-06-16 Weird Science LLC PROCEDURES AND COMPOSITIONS FOR NON-MYELOABLATIVE BONE MARROW RECONSTITUTION
EP3820486A4 (en) 2018-07-15 2022-05-04 Enochian Biopharma, Inc. METHODS AND COMPOSITIONS USING RECOMBINANT DENDRITIC CELLS FOR CANCER THERAPY
WO2021155351A1 (en) * 2020-01-31 2021-08-05 Gumrukcu Serhat Compositions and methods for providing chemoprotective effects

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766072A (en) * 1985-07-17 1988-08-23 Promega Corporation Vectors for in vitro production of RNA copies of either strand of a cloned DNA sequence
AU3969993A (en) * 1992-04-01 1993-11-08 Cornell Research Foundation Inc. Method and recombinant cells for providing increased resistance of hematopoietic progenitor cells to toxicity of chemotherapeutic agents
IL109168A0 (en) 1993-04-01 1994-06-24 Univ Columbia A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and making cells resistant to the chemotherapeutic agent cyclophosphamide and its derivatives and analogs

Also Published As

Publication number Publication date
PL306549A1 (en) 1995-04-03
RU94046095A (ru) 1997-03-27
US5888820A (en) 1999-03-30
CA2135912A1 (en) 1994-10-13
WO1994023015A1 (en) 1994-10-13
IL109168A0 (en) 1994-06-24
EP0648261A1 (en) 1995-04-19
HUT75717A (en) 1997-05-28
JPH08501221A (ja) 1996-02-13
EP0648261A4 (en) 1997-10-22
US6268138B1 (en) 2001-07-31
NZ265472A (en) 1996-10-28
HU9403377D0 (en) 1995-02-28
FI945665A (fi) 1994-12-01
CN1109260A (zh) 1995-09-27
KR950701969A (ko) 1995-05-17
AU6623994A (en) 1994-10-24

Similar Documents

Publication Publication Date Title
FI945665A0 (fi) Retrovirusvektori, joka kykenee transdusoimaan aldehydidehydrogenaasi-1-geenin ja mainitun vektorin käyttö
EE9600123A (et) 4,4-difluorobut-3-enüültio)-rühmaga asendatud heterotsüklilised või karbotsüklilised pestitsiidse aktiivsusega ühendid
DE3887990D1 (de) Dehydrogenierungskatalysator und dessen verwendung.
DE69420799D1 (de) Dehydrogenierung
DK0687400T3 (da) Transducer
NO882116D0 (no) Eksotermt, ledende belegg og anvendelse av dette.
NO891726D0 (no) Anti-isingsbeleggblandinger.
DE58909390D1 (de) Sulfonylaminocarbonyltriazolinone.
DE68902400D1 (de) Harte ueberzugsmittel.
NO891028D0 (no) Lyd- og/eller vibrasjonsdempende belegg, element paafoert belegget og fremgangsmaate ved paafoering.
FR2692711B1 (fr) Transducteur magnetoresistif.
FI935644A0 (fi) Retrovirala proteasinhibitorer
FI940483A0 (fi) Uudet herbisidit
NO891503D0 (no) Elektroakustisk omvandler uten retningskarakteristikk.
DE69304742D1 (de) Beschichteter Hartmetallkörper
BR9400029A (pt) Composto, e, material fototermográfico
DE69421273D1 (de) Kristallisation von 2,6-dimethylnaphthalin
NO894350L (no) Pyrrolokinolin- og pyrrolofenotiazinkarboksamider og beslektede forbindelser.
NO894154L (no) Pankromatisk elektrofotografisk opptegningselement, samt anvendelse av det.
DE59204051D1 (de) Verwendung von polymodalem beta-Oktogen.
NO904016L (no) Paafoerings-hjelpemiddel samt anvendelse av dette.
BR9406795A (pt) Transdutor
DK2489A (da) Anvendelse af benzimidazolderivater, benzimidazolderivater og fremstillingen heraf samt ved fremgangsmaaden anvendelige mellemprodukter og fremstillingen heraf
DE69019133D1 (de) Akustische beschichtung.
DE3670085D1 (de) 2-(1-hydroxy-2,2,6,6-tetraalkyl-piperidin-4-yloxy)-dibenzodioxaphosphepine und dibenzodioxaphosphocine.

Legal Events

Date Code Title Description
FD Application lapsed